This Biomarker Predicts Survival in Autoimmune Lung Disease
(MedPage Today) -- One major subgroup of patients with interstitial lung disease (ILD) arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 28, 2023 Category: Rheumatology Source Type: news

Trends in Dermatomyositis and Polymyositis Mortality Trends in Dermatomyositis and Polymyositis Mortality
An analysis of mortality data provides insight into the mortality trends for dermatomyositis or polymyositis.Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Polymyositis-Dermatomyositis Tied to Arrhythmias in Young, Middle-Aged Adults Polymyositis-Dermatomyositis Tied to Arrhythmias in Young, Middle-Aged Adults
Young and middle-aged adults with polymyositis-dermatomyositis are more likely to have arrhythmias than matched controls without these rare rheumatic conditions, a US study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 18, 2021 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
TITUSVILLE, N.J., January 21, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir), the first and only once-monthly, long-acting regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. The novel regimen was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen’s 25-year commitment to make HIV history. In the U.S., ViiV Healthcare is the marketing authorization holder for CABENUVA.C...
Source: Johnson and Johnson - January 22, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Polymyositis and Dermatomyositis
Title: Polymyositis and DermatomyositisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/4/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 4, 2021 Category: Rheumatology Source Type: news

Polymyositis: Can it affect my lungs?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - April 20, 2020 Category: Consumer Health News Source Type: news

Methylprednisolone and dental implants?
I have a 50-year old female patient with polymyositis taking methylprednisolone, for whom I am considering implant placement. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - August 22, 2017 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news

Polymyositis : Can it affect my lungs?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - June 30, 2017 Category: Consumer Health News Source Type: news

Polymyositis: Can a gluten-free diet reduce symptoms?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - January 19, 2017 Category: Consumer Health News Source Type: news

Polymyositis
Title: PolymyositisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/18/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - May 18, 2016 Category: Rheumatology Source Type: news

Polymyositis/Dermatomyositis Associated With High Rate of Diastolic Dysfunction (CME/CE)
(MedPage Today) -- Inflammation appears to be underlying pathology (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 6, 2015 Category: Rheumatology Source Type: news

VTE Risk High in Autoimmune Muscle Disease
(MedPage Today) -- Patients with the inflammatory myopathies polymyositis and dermatomyositis had markedly elevated risks for venous thromboembolic events, a population-based study in Canada found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 9, 2014 Category: Cardiology Source Type: news

Polymyositis: Can a gluten-free diet reduce symptoms?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - May 8, 2014 Category: Consumer Health News Source Type: news

Polymyositis
Title: PolymyositisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/19/2013 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 19, 2013 Category: Rheumatology Source Type: news

What Causes Spontaneous Pneumothorax?
Discussion “A pneumothorax is a collection of air in the pleural space, and it can be categorized into spontaneous, traumatic or iatrogenic. Spontaneous pneumothorax can be further classified into primary with no clinical evidence of underlying lung disease or secondary due to pre-existing lung disease.” Spontaneous pneumothorax is a condition that is relatively rare in pediatrics. There is a bimodal age distribution – neonates and late adolescence. It is caused by tearing of the visceral pleural. Clinical signs include chest pain, dyspnea, tachycardia, tracheal deviation towards contralateral side, hypo...
Source: PediatricEducation.org - May 20, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news